In addition, USP47 is positively correlated with the expression of YB-1 in primary CML cells, and CML cells with higher levels of USP47 are more sensitive to P22077 treatment than the cells with lower levels of USP47 (Supplementary Fig. 7a). This evidence concerns the gene YBX1 and chronic myelogenous leukemia, BCR-ABL1 positive.